Triple fixed-dose combination empagliflozin, linagliptin, and metformin for patients with type 2 diabetes

Ildiko Lingvay, Nadine Beetz, Regina Sennewald, Annette Schuler-Metz, Julia Bertulis, Christina Loley, Benjamin Lang, Caroline Lippert, Jisoo Lee, Linda Shapiro Manning, Derek Terada

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Fingerprint

Dive into the research topics of 'Triple fixed-dose combination empagliflozin, linagliptin, and metformin for patients with type 2 diabetes'. Together they form a unique fingerprint.

Medicine & Life Sciences